Hologic Share Price (NASDAQ: HOLX)

$66.7

▲

-0.43

(-0.64%)

Last updated on August 27, 2025 at 1:29 AM IST

$₹

Check the interactive Hologic Stock chart to analyse performance

Hologic stock performance

as on August 27, 2025 at 1:29 AM IST

Today's Low:$66.51
Today's High:$67.03
$66.70
0.28%
Downside
Day's Volatility :0.78%
Upside
0.49%
52 Weeks Low:$51.90
52 Weeks High:$84.39
$66.70
22.19%
Downside
52 Weeks Volatility :38.5%
Upside
20.96%

Hologic Stock Returns

Period	Hologic Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	4.68%	3.1%	0.0%
6 Months	3.62%	-7.5%	0.0%
1 Year	-16.33%	-12.5%	0.0%
3 Years	-1.11%	7.0%	-6.9%

Hologic Inc. Key Stats

Check Hologic key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$67.13
Open	$67.0
Today's High	$67.03
Today's Low	$66.51
Market Capitalization	$14.9B
Today's Volume	$3.0M
52 Week High	$84.39
52 Week Low	$51.9
Revenue TTM	$4.0B
EBITDA	$1.2B
Earnings Per Share (EPS)	$2.41
PE Ratio	27.85
Profit Margin	13.79%
Quarterly Earnings Growth YOY	0.05%
Return On Equity TTM	11.38%

Stock Returns calculator for Hologic Stock including INR - Dollar returns

The Hologic stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Hologic investment value today

Current value as on today

₹88,104

Returns

₹11,896

(-11.9%)

Returns from Hologic Stock

₹16,322 (-16.32%)

Dollar Returns*

₹4,426 (+4.43%)

Indian investors sentiment towards Hologic Stock

67%

Period: Jul 27, 2025 to Aug 26, 2025. Change in 30 Days versus previous period

Search interest for Hologic Stock from India on INDmoney has increased by 67% in the last 30 days, reflecting an upward trend in search activity.

Indian Mutual Funds that invest in Hologic Stock

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	1801	-2.38	0.03%

Global Institutional Holdings in Hologic Inc.

Name
Holdings %
Name
Holdings %
Vanguard Group Inc
12.05%
T. Rowe Price Investment Management,Inc.
10.83%
BlackRock Inc
9.61%
Manufacturers Life Insurance Co
4.96%
Morgan Stanley - Brokerage Accounts
4.59%
State Street Corp
4.55%

Analyst Recommendation on Hologic Stock

Rating

Trend

Buy

62%Buy

37%Hold

0%Sell

Based on 24 Wall street analysts offering stock ratings for Hologic(by analysts ranked 0 to 5 stars)

Hologic Share Price Target

What analysts predicted

Upside of 10.04%

Target:

$73.40

Current:

$66.70

Hologic share price target is $73.40, a slight Upside of 10.04% compared to current price of $66.70 as per analysts' prediction.

Hologic Stock Insights

Price Movement
In the last 7 days, HOLX stock has moved down by -2.4%
Increasing Revenue
Revenue is up for the last 2 quarters, 1.00B → 1.02B (in $), with an average increase of 1.8% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -17.4M → 194.9M (in $), with an average increase of 108.9% per quarter
HOLX vs RMD (1 yr)
In the last 1 year, Resmed Inc. has given 17.9% return, outperforming this stock by 33.7%
HOLX vs ISRG (3 yr)
In the last 3 years, Intuitive Surgical, Inc. has given 29.2% return, outperforming this stock by 30.1%
Price to Sales
ForHOLX every $1 of sales, investors are willing to pay $3.8, whereas for Resmed Inc., the investors are paying $8.1 for every $1 of sales.

Hologic Inc. Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$3.4B	↑ 4.64%
Net Income	$-40.2M	↓ 63.88%
Net Profit Margin	-1.19%	↑ 2.27%

	FY20	Y/Y Change
Revenue	$3.8B	↑ 12.15%
Net Income	$1.1B	↓ 2874.13%
Net Profit Margin	29.53%	↑ 30.72%

	FY21	Y/Y Change
Revenue	$5.6B	↑ 49.14%
Net Income	$1.9B	↑ 67.82%
Net Profit Margin	33.23%	↑ 3.7%

	FY22	Y/Y Change
Revenue	$4.9B	↓ 13.66%
Net Income	$1.3B	↓ 30.43%
Net Profit Margin	26.77%	↓ 6.46%

	FY23	Y/Y Change
Revenue	$4.0B	↓ 17.12%
Net Income	$456.0M	↓ 64.98%
Net Profit Margin	11.31%	↓ 15.46%

	FY24	Y/Y Change
Revenue	$4.0B	↑ 0.0%
Net Income	$789.5M	↑ 73.14%
Net Profit Margin	19.59%	↑ 8.28%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$1.0B	↑ 0.46%
Net Income	$169.9M	↓ 31.08%
Net Profit Margin	16.69%	↓ 7.64%

	Q2 FY24	Q/Q Change
Revenue	$1.0B	↓ 0.63%
Net Income	$194.5M	↑ 14.48%
Net Profit Margin	19.23%	↑ 2.54%

	Q3 FY24	Q/Q Change
Revenue	$987.9M	↓ 2.32%
Net Income	$178.6M	↓ 8.17%
Net Profit Margin	18.08%	↓ 1.15%

	Q4 FY24	Q/Q Change
Revenue	$1.0B	↑ 3.43%
Net Income	$201.0M	↑ 12.54%
Net Profit Margin	19.67%	↑ 1.59%

	Q1 FY25	Q/Q Change
Revenue	$1.0B	↓ 1.61%
Net Income	$-17.4M	↓ 108.66%
Net Profit Margin	-1.73%	↓ 21.4%

	Q2 FY25	Q/Q Change
Revenue	$1.0B	↑ 1.84%
Net Income	$194.9M	↓ 1220.11%
Net Profit Margin	19.04%	↑ 20.77%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$1.3B	↓ 22.9%

	FY20	Y/Y Change
Profit	$2.2B	↑ 70.29%

	FY21	Y/Y Change
Profit	$3.8B	↑ 70.41%

	FY22	Y/Y Change
Profit	$3.0B	↓ 21.03%

	FY23	Y/Y Change
Profit	$2.1B	↓ 30.89%

	FY24	Y/Y Change
Profit	$2.2B	↑ 7.55%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$562.5M	↓ 0.88%

	Q2 FY24	Q/Q Change
Profit	$568.3M	↑ 1.03%

	Q3 FY24	Q/Q Change
Profit	$557.6M	↓ 1.88%

	Q4 FY24	Q/Q Change
Profit	$575.8M	↑ 3.26%

	Q1 FY25	Q/Q Change
Profit	$382.0M	↓ 33.66%

	Q2 FY25	Q/Q Change
Profit	$576.6M	↑ 50.94%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$649.5M	↓ 11.38%
Investing Cash Flow	$-280.7M	↑ 43.8%
Financing Cash Flow	$-431.5M	↑ 6.6%

	FY20	Y/Y Change
Operating Cash Flow	$896.6M	↑ 38.04%
Investing Cash Flow	$-141.6M	↓ 49.55%
Financing Cash Flow	$-659.9M	↑ 52.93%

	FY21	Y/Y Change
Operating Cash Flow	$2.3B	↑ 159.92%
Investing Cash Flow	$-1.3B	↑ 838.98%
Financing Cash Flow	$-529.8M	↓ 19.72%

	FY22	Y/Y Change
Operating Cash Flow	$2.1B	↓ 8.78%
Investing Cash Flow	$-206.3M	↓ 84.48%
Financing Cash Flow	$-756.0M	↑ 42.7%

	FY23	Y/Y Change
Operating Cash Flow	$1.1B	↓ 50.55%
Investing Cash Flow	$-152.1M	↓ 26.27%
Financing Cash Flow	$-483.2M	↓ 36.08%

	FY24	Y/Y Change
Operating Cash Flow	$1.3B	↑ 22.26%
Investing Cash Flow	$-781.0M	↑ 413.48%
Financing Cash Flow	$-1.1B	↑ 129.43%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$292.4M	↑ 32.91%
Investing Cash Flow	$-38.5M	↓ 63.05%
Financing Cash Flow	$-4.2M	↓ 99.55%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$405.8M	↑ 38.78%
Investing Cash Flow	$-42.6M	↑ 10.65%
Financing Cash Flow	$-103.8M	↑ 2371.43%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$367.0M	↓ 9.56%
Investing Cash Flow	$-595.7M	↑ 1298.36%
Financing Cash Flow	$-56.8M	↓ 45.28%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$189.3M	↓ 48.42%
Investing Cash Flow	$-22.0M	↓ 96.31%
Financing Cash Flow	$-537.0M	↑ 845.42%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$169.4M	↓ 10.51%
Investing Cash Flow	$-324.3M	↑ 1374.09%
Financing Cash Flow	$-201.7M	↓ 62.44%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$343.3M	↑ 102.66%
Investing Cash Flow	$-4.3M	↓ 98.67%
Financing Cash Flow	$-40.1M	↓ 80.12%

Hologic Technicals Summary

Sell

Neutral

Buy

Hologic is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Hologic Inc. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Hologic Inc.	2.16%	3.62%	-16.33%	-1.11%	10.47%
Intuitive Surgical, Inc.	-3.99%	-18.37%	-1.68%	127.01%	95.69%
Alcon Ag	-9.66%	-12.72%	-15.21%	23.57%	41.27%
West Pharmaceutical Services Inc	-5.12%	11.3%	-19.19%	-18.91%	-9.95%
Resmed Inc.	4.25%	21.53%	17.7%	29.23%	58.2%
Becton, Dickinson And Company	6.09%	-14.73%	-18.45%	-23.72%	-20.07%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Hologic Inc.	27.85	27.85	1.5	4.24	0.11	0.07	NA	21.79
Intuitive Surgical, Inc.	66.23	66.23	3.49	8.12	0.16	0.09	NA	49.79
Alcon Ag	37.97	37.97	2.23	3.09	0.05	0.03	0.0	44.73
West Pharmaceutical Services Inc	37.05	37.05	3.58	6.76	0.18	0.11	0.0	40.74
Resmed Inc.	30.85	30.85	1.98	9.5	0.26	0.14	0.01	40.77
Becton, Dickinson And Company	36.5	36.5	1.0	14.37	0.06	0.04	0.02	88.87

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Hologic Inc.	Buy	$14.9B	10.47%	27.85	13.79%
Intuitive Surgical, Inc.	Buy	$170.7B	95.69%	66.23	28.51%
Alcon Ag	Buy	$40.6B	41.27%	37.97	10.7%
West Pharmaceutical Services Inc	Buy	$17.8B	-9.95%	37.05	16.48%
Resmed Inc.	Buy	$43.0B	58.2%	30.85	27.22%
Becton, Dickinson And Company	Buy	$57.2B	-20.07%	36.5	7.41%

About Hologic Inc.

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, and specimen radiology solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. The company was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Organization	Hologic
Employees	7063
CEO	Mr. Stephen P. MacMillan
Industry	Health Technology

Key Management of Hologic Inc.

Name	Title
Mr. Stephen P. MacMillan	Chairman, CEO & President
Ms. Karleen M. Oberton CPA	Chief Financial Officer
Mr. Essex D. Mitchell	Chief Operating Officer
Mr. Jan Verstreken	Group President of International
Mr. Paul Malenchini	Chief Information Officer
Mr. Michael J. Watts	Corporate Vice President of Investor Relations
Ms. Anne Liddy	General Counsel
Ms. Diana De Walt SPHR	Senior Vice President of Global Human Resources
Ms. Monica Aguirre Berthelot	VP & Chief of Staff
Dr. Jennifer M. Schneiders Ph.D.	Division President of Diagnostic Solutions

Important FAQs about investing in HOLX Stock from India :

What is Hologic share price today?

Hologic share price today is $66.70 as on August 27, 2025 at 1:29 AM IST at the close of the market. Hologic share today touched a day high of $67.03 and a low of $66.51.

What is the 52 week high and 52 week low for Hologic share?

Hologic share touched a 52 week high of $84.39 and a 52 week low of $51.90. Hologic stock price today i.e. August 27, 2025 at 1:29 AM IST is closed at $66.70, lower by 20.96% versus the 52 week high.

How to invest in Hologic Stock (HOLX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Hologic on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Hologic Shares that will get you 0.0225 shares as per Hologic share price of $66.70 per share as on August 27, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Hologic Stock (HOLX) from India?

Indian investors can start investing in Hologic (HOLX) shares with as little as ₹87.6525 or $1 (as of August 27, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹876.53 in Hologic stock (as per the Rupee-Dollar exchange rate as on August 27, 2025). Based on Hologic share’s latest price of $66.70 as on August 27, 2025 at 1:29 AM IST, you will get 0.1499 shares of Hologic. Learn more about fractional shares .

What are the returns that Hologic has given to Indian investors in the last 5 years?

Hologic stock has given 10.47% share price returns and 18.61% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?